704 related articles for article (PubMed ID: 8104652)
1. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
Momiyama T; Todo N; Sasa M
Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area.
Momiyama T; Sasa M; Takaori S
Br J Pharmacol; 1993 Oct; 110(2):713-8. PubMed ID: 7902179
[TBL] [Abstract][Full Text] [Related]
3. Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta.
Lacey MG; Mercuri NB; North RA
J Physiol; 1987 Nov; 392():397-416. PubMed ID: 2451725
[TBL] [Abstract][Full Text] [Related]
4. Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation.
Harvey J; Lacey MG
J Physiol; 1996 Apr; 492 ( Pt 1)(Pt 1):143-54. PubMed ID: 8730590
[TBL] [Abstract][Full Text] [Related]
5. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
Hu XT; Brooderson RJ; White FJ
Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory action of dopamine involves a subthreshold Cs(+)-sensitive conductance in neostriatal neurons.
Pacheco-Cano MT; Bargas J; Hernández-López S; Tapia D; Galarraga E
Exp Brain Res; 1996 Jul; 110(2):205-11. PubMed ID: 8836685
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin octapeptide potentiates the inhibitory response mediated by D2 dopamine receptors in slices of the ventral tegmental area of the brain in the rat.
Stittsworth JD; Mueller AL
Neuropharmacology; 1990 Feb; 29(2):119-27. PubMed ID: 2184375
[TBL] [Abstract][Full Text] [Related]
8. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement.
Calabresi P; Mercuri N; Stanzione P; Stefani A; Bernardi G
Neuroscience; 1987 Mar; 20(3):757-71. PubMed ID: 2955246
[TBL] [Abstract][Full Text] [Related]
9. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
10. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
11. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D2 receptor activation depolarizes rat supraoptic neurones in hypothalamic explants.
Yang CR; Bourque CW; Renaud LP
J Physiol; 1991 Nov; 443():405-19. PubMed ID: 1688025
[TBL] [Abstract][Full Text] [Related]
14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area.
Momiyama T; Amano T; Todo N; Sasa M
Eur J Pharmacol; 1996 Aug; 310(1):1-8. PubMed ID: 8880060
[TBL] [Abstract][Full Text] [Related]
16. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats.
Borowsky B; Kuhn CM
Neuropharmacology; 1992 Jul; 31(7):671-8. PubMed ID: 1328919
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
Wang HY; Zhou LW; Friedman E; Weiss B
Neuropharmacology; 1993 Jan; 32(1):85-91. PubMed ID: 8094235
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones.
Koga E; Momiyama T
J Physiol; 2000 Feb; 523 Pt 1(Pt 1):163-73. PubMed ID: 10673553
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective D1 and D2 dopamine agonists on cockroach salivary gland acinar cells in vitro.
Evans AM; Green KL
Br J Pharmacol; 1991 Dec; 104(4):787-92. PubMed ID: 1687366
[TBL] [Abstract][Full Text] [Related]
20. Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
Kamijo N; Nagao T; Ono H
Neuropharmacology; 1993 Aug; 32(8):777-83. PubMed ID: 8105410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
